Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$737M |
| 2 |
American Tower
AMT
|
+$687M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$554M |
| 4 |
Abbott
ABT
|
+$553M |
| 5 |
SLB Ltd
SLB
|
+$449M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$1.06B |
| 2 |
Netflix
NFLX
|
+$816M |
| 3 |
Match Group
MTCH
|
+$678M |
| 4 |
NVIDIA
NVDA
|
+$611M |
| 5 |
Intuitive Surgical
ISRG
|
+$530M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.17% |
| 2 | Consumer Discretionary | 21.87% |
| 3 | Healthcare | 15.92% |
| 4 | Financials | 9.87% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
551
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $751K | ﹤0.01% |
+13,151
| New | +$746K |
|
552
Lincoln National
LNC
$8.73B
| $747K | ﹤0.01% |
+15,976
| New | +$911K |
|
553
Crown Castle
CCI
$33.3B
| $742K | ﹤0.01% |
4,408
+3,048
| +224% | +$555K |
|
554
J.M. Smucker
SJM
$12.7B
| $738K | ﹤0.01% |
5,762
+1,197
| +26% | +$160K |
|
|
GMS
555
DELISTED
GMS Inc
GMS
| $737K | ﹤0.01% |
+16,558
| New | +$786K |
|
|
AEL
556
DELISTED
American Equity Investment Life Holding Company
AEL
| $728K | ﹤0.01% |
+19,896
| New | +$757K |
|
557
TTM Technologies
TTMI
$12B
| $709K | ﹤0.01% |
+56,748
| New | +$785K |
|
|
FOLD
558
DELISTED
Amicus Therapeutics
FOLD
| $707K | ﹤0.01% |
65,788
-3,502,726
| -98% | -$28.8M |
|
559
Matador Resources
MTDR
$6.2B
| $700K | ﹤0.01% |
15,029
-476
| -3% | -$25.8K |
|
|
BAND
560
Bandwidth Inc
BAND
$1.26B
| $694K | ﹤0.01% |
36,889
+291
| +0.8% | +$6.72K |
|
561
Matsons
MATX
$6.13B
| $693K | ﹤0.01% |
9,502
-3,518
| -27% | -$302K |
|
562
Green Brick Partners
GRBK
$3.04B
| $689K | ﹤0.01% |
+35,198
| New | +$739K |
|
563
Vanguard Morningstar Growth ETF
VUG
$220B
| $689K | ﹤0.01% |
18,546
+7,524
| +68% | +$309K |
|
564
Newmark Group
NMRK
$2.66B
| $687K | ﹤0.01% |
71,068
+20,940
| +42% | +$242K |
|
565
Dorian LPG
LPG
$2.03B
| $678K | ﹤0.01% |
+44,624
| New | +$707K |
|
|
ATSG
566
DELISTED
Air Transport Services Group
ATSG
| $678K | ﹤0.01% |
+23,608
| New | +$719K |
|
567
Pacific Biosciences
PACB
$435M
| $677K | ﹤0.01% |
153,165
+70,949
| +86% | +$431K |
|
|
MDRX
568
DELISTED
Veradigm Inc. Common Stock
MDRX
| $675K | ﹤0.01% |
45,489
-4,496
| -9% | -$84.1K |
|
569
Morningstar
MORN
$7.22B
| $671K | ﹤0.01% |
2,774
-2,129
| -43% | -$537K |
|
570
Cognizant
CTSH
$24.9B
| $663K | ﹤0.01% |
9,823
+4,932
| +101% | +$377K |
|
571
AMN Healthcare
AMN
$1.3B
| $655K | ﹤0.01% |
5,970
-3,629
| -38% | -$359K |
|
572
Prothena Corp
PRTA
$425M
| $652K | ﹤0.01% |
24,016
-29
| -0.1% | -$848 |
|
|
AQUA
573
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $652K | ﹤0.01% |
20,068
+489
| +2% | +$18.6K |
|
574
Sinclair Inc
SBGI
$992M
| $650K | ﹤0.01% |
+31,843
| New | +$739K |
|
|
NEX
575
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $642K | ﹤0.01% |
+67,501
| New | +$708K |
|
Similar funds
Jennison Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Jennison Associates held 720 positions worth $100B, down 26% from $136B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Jennison Associates withdrew a net $3.7B in Q2 2022, closing 106 positions and reducing 265 holdings. Its most notable exit was Okta, an estimated $272M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in KBR worth $40.4M.
- Jennison Associates's largest Q2 2022 buy was KBR: 834,334 shares worth $40.4M.
- Jennison Associates added most to Eli Lilly in Q2 2022, an estimated $737M increase.
- Jennison Associates's biggest Q2 2022 reduction was Shopify, cutting an estimated $1.06B.
- Jennison Associates fully exited Okta in Q2 2022, selling an estimated $272M.
- Jennison Associates's ten largest holdings make up 41% of its $100B portfolio in Q2 2022.
- Jennison Associates opened 95 new positions and closed 106 in Q2 2022.
- Jennison Associates's portfolio value fell 26% quarter-over-quarter to $100B.
Based on Jennison Associates's 13F filing for Q2 2022, filed 2 Aug 2022.